metricas
covid
Clinics Treatment with dasatinib or nilotinib in chronic myeloid leukemia patients who f...
Journal Information

Statistics

Follow this link to access the full text of the article

CLINICAL SCIENCE
Treatment with dasatinib or nilotinib in chronic myeloid leukemia patients who failed to respond to two previously administered tyrosine kinase inhibitors – a single center experience
Beatriz Felicio Ribeiro, Eliana C M Miranda, Dulcinéia Martins de Albuquerque, Márcia T Delamain, Gislaine Oliveira-Duarte, Maria Helena Almeida, Bruna Vergílio, Rosana Antunes da Silveira, Vagner Oliveira-Duarte, Irene Lorand-Metze, Carmino A De Souza, Katia B B Pagnano
Corresponding author
kborgia@unicamp.br

Corresponding author:
Universidade de Campinas (Unicamp), Centro de Hematologia e Hemoterapia Campinas/SP, Brazil
Read
2777
Times
was read the article
814
Total PDF
1963
Total HTML
Share statistics
Article information
ISSN: 18075932
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 58 39 97
2025 11 146 141 287
2025 10 78 57 135
2025 9 70 40 110
2025 8 92 31 123
2025 7 108 39 147
2025 6 56 12 68
2025 5 64 11 75
2025 4 68 11 79
2025 3 71 12 83
2025 2 52 7 59
2025 1 77 7 84
2024 12 52 9 61
2024 11 59 21 80
2024 10 41 24 65
2024 9 54 38 92
2024 8 49 41 90
2024 7 60 36 96
2024 6 46 24 70
2024 5 40 24 64
2024 4 41 20 61
2024 3 65 19 84
2024 2 63 15 78
2024 1 84 13 97
2023 12 41 16 57
2023 11 45 28 73
2023 10 44 18 62
2023 9 27 16 43
2023 8 15 1 16
2023 7 23 13 36
2023 6 24 6 30
2023 5 41 2 43
2023 4 39 1 40
2023 3 34 1 35
2023 2 14 3 17
2023 1 16 7 23
2022 12 6 11 17
Show all

Follow this link to access the full text of the article